The Management Of Patients With Severe Aplastic Anemia In Oral & Maxillofacial Surgery.
- Author:
Hyun Joong YOON
1
;
Je Uk PARK
Author Information
1. Div. of Oral & Maxillofacial Surgery, Department of dentistry College of Medicine, The Catholic University of Korea. E-Mail: jupark@cmc.cuk.ac.kr
- Publication Type:Original Article
- Keywords:
Severe aplastic anemia;
Platelet;
Alloimmunization
- MeSH:
Anemia, Aplastic*;
Blood Platelets;
Bone Marrow;
Hemorrhage;
Humans;
Leukopenia;
Molar, Third;
Pancytopenia;
Surgery, Oral*;
Thrombocytopenia;
Tooth
- From:Journal of the Korean Association of Oral and Maxillofacial Surgeons
2001;27(5):464-467
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Aplastic anemia is a hematopoietic disorder characterized by marked reduction or absence of erythoid, granulocytic, and megakariocytic cells in the bone marrow with resultant pancytopenia. To control of infection & bleeding secondary to leukopenia and thrombocytopenia, the inflammatory lesions in oral & maxillofacial area should be removed. MATERIALS AND METHOD: The extractions were performed on 21 patients with severe aplastic anemia. The initial, pre-operative and postoperative CBCs were checked up. Amount and kind of transfused platelet in each patient and increment of platelet level were recorded. The complications were documented. RESULT: A mean of 2.9 teeth were extracted from each patient(ranging between 1 and 13). Furthermore, surgical extractions including ostectomy and odontectomy of the third molar were performed on 11 patients. The preoperative WBC levels presented between 600/muL and 5000/muL(mean 2376/muL). The WBC values decreased by an average of 145/muL per patient after extractions had been performed. The teeth of 16 patients were extracted under 10.0g/dL, and the mean change in postoperative hemoglobin levels in comparison with preoperative hemoglobin levels was -0.06 per patient. The initial platelet levels were between 1000/(L and 81,000/muL(mean 20,174/muL). In five patients, extractions were performed with platelet levels less than 50,000/muL. CONCLUSION: The results suggest that more active and preventive treatments in the oral and maxillofacial area are possible and are necessary to remove the infectious foci on the patients with severe aplastic anemia. We report the results of our experiences and literature reviews in treatment of the patients with severe aplastic anemia in our department.
